Physician

Michael Christopher Abowd, M.D.

According to 2025 Medicare claims, Michael Abowd, M.D. (NPI: 1972575371) practices ophthalmology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is PROMEDICA CENTRAL PHYSICIANS (NPI: 1043270150; TIN: 341881137) and primary practice location at 43617-3103. Abowd is affiliated with the ProMedica Health Network, Inc. (ACO ID: A3016), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Abowd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 943 traditional Medicare patients, billed 3,313 HCPCS/CPT codes, and received $351,722 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,471 prescription claims across 696 beneficiaries totaling $86,711 in drug costs, led by Restasis (Cyclosporine). 2020 DME data shows 20 claims. Open Payments data shows 2 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $112,908 and ending at $86,711. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	764	2,655	$250,310
2016	944	3,561	$310,381
2017	1,020	3,838	$335,512
2018	1,120	4,443	$353,633
2019	1,025	4,199	$359,448
2020	821	3,002	$239,712
2021	832	3,393	$239,710
2022	912	3,431	$242,830
2023	926	3,555	$305,025
2024	943	3,313	$351,722

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	534	1,589	$112,908
2016	507	1,485	$116,987
2017	521	1,505	$86,497
2018	610	1,654	$80,972
2019	612	1,556	$107,208
2020	527	1,404	$106,966
2021	520	1,340	$117,275
2022	570	1,282	$79,674
2023	563	1,246	$75,531
2024	696	1,471	$86,711

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	33	33	$2,460
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	28	28	$2,142
2019	30	30	$2,223
2020	20	20	$1,027
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	177	177	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	290	304	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	238	293	$63
92081	Exam of visual field with limited testing	164	164	$20
92285	Photography of content of eyes	172	172	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	30	1,320	$23,579
Restasis Multidose	Cyclosporine	11	624	$12,700
Cyclosporine	Cyclosporine	20	1,200	$11,601
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	88	2,382	$3,788
Prednisolone Acetate	Prednisolone Acetate	146	4,210	$3,535

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$31	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Christopher Abowd, M.D.?

Tedicare shows public-source Medicare data for Michael Christopher Abowd, M.D. (NPI 1972575371), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Christopher Abowd, M.D. have ACO affiliation data?

Michael Christopher Abowd, M.D. is shown with ACO affiliation data for ProMedica Health Network, Inc. (MSSP, ACO ID A3016), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Michael Christopher Abowd, M.D.?

Michael Christopher Abowd, M.D. is linked to PROMEDICA CENTRAL PHYSICIANS (billing NPI 1043270150) in the available physician profile data.

Does Michael Christopher Abowd, M.D. have Open Payments data?

Michael Christopher Abowd, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.